HLA-G and neoplasm: Considering the functional implication of the HLA-G/ILT-2 ligand-receptor axis as an IC in the tumor evolution, we hypothesized that sHLA-G, together with the genetic background of regulatory regions of HLA-G or ILT-2 expression, were relevant for risk assessment of TNBC patients.